Many Patients, Survivors, Family Members and Friends came out to the Rally held outside the FDA Building an hour before the Hearing Day #1 began on Tuesday.
View the Video of FAMEDS’ Terry Kalley Speaking at the Rally & Photos: www.fameds.org/hearing.php
INSIDE THE HEARING
The FDA Avastin Hearing kicked off with a 2 hour public testimony from patients and family members sharing their emotional stories of how Avastin has improved their quality of life. FAMEDS’ Founder Terry Kalley was one of the few granted to speak, on behalf of his wife.
View His Speech: www.fameds.org/documents/avastin_speech.pdf
View Powerpoint Presentation: www.fameds.org/documents/kalley_presentation_fda.ppt
Next spoke an FDA lawyer to read over the key legal issues of the drug and FDA. Directly following, CDER, Center for Drug Evaluation and Research, which spoke on data from trials and some of the science behind the drug. After CDER, the Roche/Genentech cross examination of the FDA began. It appeared as a court room with FDA officials on the stand. The FDA cited other drugs / products are irrelevant & should not be discussed. (A larger recap will be included in tomorrow’s newsletter.)
From the Hearing, FAMEDS went to Capitol Hill and held a press conference with Media outlets. Then they went to visit senators and congressmen, including US Rep Marsha Blackburn who is on the Energy and Commerce Health committee.
AVASTIN IN THE MEDIA
FAMEDS Founder Terry Kalley will be Interviewed on Fox News on Wednesday at 10:45AM EST. Please watch for the segment!
As expected, Avastin received a great deal of media coverage on Radio, TV, in Newspapers and on the web on Day #1 of the FDA Hearing. Advocacy Organization Komen for the Cure is in favor of continued coverage for Avastin Patients. Here are some highlights of articles worth reading:
Susan G. Komen for the Cure® Encourages Continued Coverage for Avastin
– via Komen
Statement Regarding Avastin from Susan G. Komen for the Cure®
- via Komen
Patients, scientists at odds over breast cancer drug
– via CNN
Breast cancer patients outraged over drug debate
– via CBS News
Patients plead to keep Avastin for breast cancer
Genentech Prepares to Vouch for Avastin’s Use in Breast Cancer in FDA Hearing
– via Genetic Engineering & Biotechnology News.
FAMEDS IN THE MEDIA
Air Talk with Larry Mantle
– Radio Interview on Tuesday, June 28
Eliminating Avastin will be a death sentence for some cancer victims
– OpEd by Arlene Kalley, Avastin Patient – via MercuryNews.com
An FDA Panel Is Deciding Life or Death For My Wife
– via FoxNews by Terry Kalley
For the Rally, FAMEDS printed and purchased many flyers, signs, banners, t-shirts, and rented a shuttle to Capitol Hill among other costs. Please consider helping and giving a tax-deductible donation of any amount: www.fameds.org/makeadonation.php
We greatly appreciate our supporters!